Medimaps Group is an innovative Swiss based company that is developing seamless solutions for clinical routine.
Medimaps Group's mission is to design and provide medical tools to assist in the collection of quantitative information on bone microarchitecture for use in routine clinical practice.They enhance osteoporosis diagnosis by assessing the status of bone microarchitecture. They provide information to physicians to help them select the best treatment options for their patients and monitor treatment outcomes. They are working on future products to assess bone microarchitecture for application in the dental and orthopedic fields.
Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
---|---|---|---|---|---|---|
Dec 1, 2021 | Series Unknown | $20M | 2 | — | — | Detail |
Investor Name | Lead Investor | Funding Round |
---|---|---|
![]() |
— | Series Unknown |
![]() |
— | Series Unknown |